Analysis of the VCD protocol (bortezomib, cyclophosphamide, and dexamethasone) in the treatment of multiple myeloma. RSD [Internet]. 2023 Nov. 28 [cited 2025 Dec. 6];12(13):e42121344144. Available from: https://rsdjournal.org/rsd/article/view/44144